VICTORY CAPITAL MANAGEMENT INC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1040188 San Antonio, TX

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$32,285,348

+$7,896,363 QoQ

Shares Held

504,853

-0.3% QoQ

Ownership

0.324%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#25

of 264 holders

Holding Since

Jun 2024

7 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $597,918,972 across 29 Drug Manufacturers - Specialty & Generic names. KNSA ranks #7 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	2,122,749	$152,540,743
2	NBIX	Neurocrine Biosciences Inc	618,499	$104,241,821
3	TEVA	Teva Pharmaceutical Industries Ltd	1,575,098	$53,364,320
4	LNTH	Lantheus Holdings, Inc.	470,051	$52,147,457
5	ALKS	Alkermes plc.	916,709	$48,035,551
6	VTRS	Viatris Inc	2,683,275	$42,610,407
7	KNSA	Kiniksa Pharmaceuticals International, plc This page	504,853	$32,285,348
8	COLL	Collegium Pharmaceutical, Inc	760,252	$27,521,122

All Filings in KNSA

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,285,348	504,853	-0.3%	Shares	Sole	2026-08-07
2026-03-31	$24,388,985	506,521	-1.1%	Shares	Sole	2026-05-15
2025-12-31	$21,126,723	512,163	+768.6%	Shares	Other	2026-02-13
2025-06-30	$1,631,533	58,964	+10.6%	Shares	Sole	2025-08-13
2025-03-31	$1,184,170	53,317	+257.8%	Shares	Sole	2025-05-02
2024-09-30	$372,400	14,902	-14.1%	Shares	Sole	2024-11-05
2024-06-30	$323,793	17,343	—	Shares	Sole	2024-08-05
No filing history on record for this holder in this stock.